Travel barriers to amyloid-targeting infusion access among older adults
{{output}}
Introduction: Amyloid-targeting treatments (ATT) for Alzheimer's disease require regular infusions and caregiver accompaniment for approximately 80% of patients. Travel time to infusion sites and caregiver availability can there... ...
